FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Bowden

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Devices

Placebos

Co-author Network

Publications

TOP 3
Vivek Singh; Charles L Bowden; Jim Mintz
Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
Vivek Singh; Peter Thompson; Charles L Bowden; J M Gonzalez; M M Katz; T J Prihoda; C G Bernardo
Discriminating primary clinical states in bipolar disorder with a comprehensive symptom scale.
Charles L Bowden; Balarama K Gundapaneni; Onur N Karayal; Jeffrey H Schwartz; Cedric O'Gorman
Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Bowden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vivek Singh; Charles L Bowden; Jim Mintz
Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
International clinical psychopharmacology 2013;28(2):91-5.
2013: Vivek Singh; Peter Thompson; Charles L Bowden; J M Gonzalez; M M Katz; T J Prihoda; C G Bernardo
Discriminating primary clinical states in bipolar disorder with a comprehensive symptom scale.
Acta psychiatrica Scandinavica 2013;127(2):145-52.
2013: Charles L Bowden; Balarama K Gundapaneni; Onur N Karayal; Jeffrey H Schwartz; Cedric O'Gorman
Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.
Journal of affective disorders 2013;144(1-2):171-5.
2013: Fabiano Nery; Giovana B Zunta-Soares; Charles L Bowden; John P Hatch; Koji Matsuo; E Serap Monkul; Jair C Soares
Trait impulsivity is increased in bipolar disorder patients with comorbid alcohol use disorders.
Psychopathology 2013;46(3):145-52.
2012: Tom Bschor; J Angst; J M Azorin; Charles L Bowden; G Perugi; E Vieta; A H Young; S Krüger
Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany.
Journal of affective disorders 2012;142(1-3):45-52.
2012: Charles L Bowden; Vivek Singh
Lamotrigine (Lamictal IR) for the treatment of bipolar disorder.
Expert opinion on pharmacotherapy 2012;13(17):2565-71.
2012: Charles L Bowden; X Chang; M Quinones; Vivek Singh; Peter Thompson; R Weisler; Jim Mintz
Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression.
Acta psychiatrica Scandinavica 2012;126(5):342-50.
2012: Michael E Thase; Charles L Bowden; James M Eudicone; Ronald Marcus; Robert D McQuade; Michael Nashat; Berit X Carlson
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
International journal of psychiatry in clinical practice 2012;16(2):121-31.
2012: Charles L Bowden; Joseph Calabrese; Jodi Gonzalez; Terence A Ketter; Andrew A Nierenberg; M M Ostacher; R H Perlis; N A Reilly-Harrington; Vivek Singh; Michael E Thase; G S Sachs
Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD).
CNS neuroscience & therapeutics 2012;18(3):243-9.
2012: Louisa G Sylvia; Michael E Thase; Michael J Ostacher; Noreen A Reilly-Harrington; Joanne Severe; Charles L Bowden; Joseph R Calabrese; Edward S Friedman; Dan V Iosifescu; Christine I Kansky; Terence A Ketter; Michelle Keyes; Andrew C Leon; Andrew A Nierenberg
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
Clinical trials (London, England) 2012;9(1):94-101.
2012: Jean-Michel Azorin; Charles L Bowden; Alex Gamma; Giulio Perugi; Eduard Vieta; Jules Angst; Allan Young
Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study.
Journal of affective disorders 2012;136(3):710-5.
2012: Jules Angst; J M Azorin; Charles L Bowden; Alex Gamma; G Perugi; E Vieta; A H Young
Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes.
European archives of psychiatry and clinical neuroscience 2012;262(1):3-11.
2011: Jules Angst; Jean-Michel Azorin; Charles L Bowden; Alex Gamma; Giulio Perugi; Eduard Vieta; Allan H Young
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
Archives of general psychiatry 2011;68(8):791-8.
2011: Martin M Katz; Nancy Berman; Charles L Bowden; Alan Frazer
The componential approach enhances the effectiveness of 2-week trials for new antidepressants.
Journal of clinical psychopharmacology 2011;31(2):253-4.
2011: John O Brooks; Joseph F Goldberg; Terence A Ketter; David J Miklowitz; Joseph Calabrese; Charles L Bowden; Michael E Thase
Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.
The Journal of clinical psychiatry 2011;72(2):240-7.
2011: John P Houston; Terence A Ketter; Michael Case; Charles L Bowden; Elisabeth K Degenhardt; Hassan H Jamal; Mauricio Tohen
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
Journal of psychiatric research 2011;45(2):169-73.
2011: Charles L Bowden
The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder.
Neuropsychiatric disease and treatment 2011;7():87-92.
2010: Charles L Bowden
Treatment strategies for bipolar depression.
The Journal of clinical psychiatry 2010;71(5):e10.
2010: Ross J Baldessarini; Eduard Vieta; Joseph Calabrese; Mauricio Tohen; Charles L Bowden
Bipolar depression: overview and commentary.
Harvard review of psychiatry 2010;18(3):143-57.
2010: Robert M A Hirschfeld; Charles L Bowden; Namita V Vigna; Patricia Wozniak; Michelle Collins
A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
The Journal of clinical psychiatry 2010;71(4):426-32.
2010: L A Smith; V R Cornelius; J M Azorin; G Perugi; E Vieta; A H Young; Charles L Bowden
Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis.
Journal of affective disorders 2010;122(1-2):1-9.
2010: Heinz Grunze; Eduard Vieta; Guy M Goodwin; Charles L Bowden; Rasmus W Licht; Hans-Jürgen Möller; Siegfried Kasper
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2):81-109.
2010: Charles L Bowden; Sergey Mosolov; Luchezar Hranov; Eric Chen; Hussain Habil; Ronnachai Kongsakon; Robert Manfredi; Hsin-Nan Lin
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
International clinical psychopharmacology 2010;25(2):60-7.
2010: Peter Thompson; Jodi Gonzalez; Vivek Singh; John D Schoolfield; Martin M Katz; Charles L Bowden
Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS).
Psychiatry research 2010;175(3):221-6.
2010: Charles L Bowden
Comorbidities with bipolar disorders: significance, recognition, and management.
CNS spectrums 2010;15(2 Suppl 3):8-9; discussion 17.
2010: Jodi Gonzalez; Charles L Bowden; Nancy Berman; Ellen Frank; Mark S Bauer; Jane N Kogan; Margarita Alegría; David J Miklowitz
One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD.
Psychiatric services (Washington, D.C.) 2010;61(2):164-72.
2010: Charles L Bowden; Eduard Vieta; Kathleen S Ice; Jeffrey H Schwartz; Paul P Wang; Mark Versavel
Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
The Journal of clinical psychiatry 2010;71(2):130-7.
2010: Jinbo Fan; Iuliana Ionita-Laza; Matthew B McQueen; Bernie Devlin; Shaun Purcell; Stephen V Faraone; Michael H Allen; Charles L Bowden; Joseph Calabrese; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence B Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra K Patel; Gary S Sachs; Michael E Thase; Francine B Molay; Michael Escamilla; Vishwajit L Nimgaonkar; Pamela Sklar; Nan M Laird; Jordan W Smoller
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010;153B(1):29-37.
2010: Jean-Michel Azorin; Charles L Bowden; Ricardo P Garay; Giulio Perugi; Eduard Vieta; Allan H Young
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.
Neuropsychiatric disease and treatment 2010;6():37-46.
2010: Charles L Bowden
Diagnosis, treatment, and recovery maintenance in bipolar depression.
The Journal of clinical psychiatry 2010;71(1):e01.
2010: Martin M Katz; Charles L Bowden; Alan Frazer
Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements.
Journal of affective disorders 2010;120(1-3):16-23.
2009: Andrew A Nierenberg; Louisa G Sylvia; Andrew C Leon; Noreen A Reilly-Harrington; Terence A Ketter; Joseph Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Lena Novak; Dan V Iosifescu
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Clinical trials (London, England) 2009;6(6):637-48.
2009: Hader A Mansour; Michael E Talkowski; Joel Wood; Kodavali V Chowdari; Lora McClain; Konasale Prasad; Debra Montrose; Andrea Fagiolini; Edward S Friedman; Michael H Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Michael Escamilla; Stephen V Faraone; Mark D Fossey; Laszlo Gyulai; Jennifer M Loftis; Peter Hauser; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Nan Laird; Matcheri S Keshavan; Michael E Thase; David Axelson; Boris Birmaher; David Lewis; Tim Monk; Ellen Frank; David J Kupfer; Bernie Devlin; Vishwajit L Nimgaonkar
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
Bipolar disorders 2009;11(7):701-10.
2009: Charles L Bowden
Diagnosis and impact of bipolar depression.
The Journal of clinical psychiatry 2009;70(9):e32.
2009: Koji Matsuo; Mark A Nicoletti; M A M Peluso; John P Hatch; Kiyotaka Nemoto; Yoshifumi Watanabe; Fabiano Nery; E Serap Monkul; Giovana B Zunta-Soares; Charles L Bowden; Jair C Soares
Anterior cingulate volumes associated with trait impulsivity in individuals with bipolar disorder.
Bipolar disorders 2009;11(6):628-36.
2009: Mauricio Tohen; Ellen Frank; Charles L Bowden; Francesc Colom; S Nassir Ghaemi; Lakshmi N Yatham; Gin S Malhi; Joseph Calabrese; Willem A Nolen; Eduard Vieta; Flávio Kapczinski; Guy M Goodwin; Trisha Suppes; Gary S Sachs; Kn Roy Chengappa; Heinz Grunze; Philip B Mitchell; Shigenobu Kanba; Michael Berk
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Bipolar disorders 2009;11(5):453-73.
2009: Koji Matsuo; Consuelo Walss-Bass; Fabiano Nery; Mark A Nicoletti; John P Hatch; Benício N Frey; E Serap Monkul; Giovana B Zunta-Soares; Charles L Bowden; Michael Escamilla; Jair C Soares
Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(8):1904-13.
2009: M A Frye; L Yatham; T A Ketter; J Goldberg; T Suppes; Joseph Calabrese; Charles L Bowden; E Bourne; Rebecca S Bahn; B Adams
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
Acta psychiatrica Scandinavica 2009;120(1):10-3.
2009: Mauricio Tohen; Virginia K Sutton; Joseph Calabrese; Gary S Sachs; Charles L Bowden
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Journal of affective disorders 2009;116(1-2):43-50.
2009: Charles L Bowden
Anticonvulsants in bipolar disorders: current research and practice and future directions.
Bipolar disorders 2009;11 Suppl 2():20-33.
2009: Roy H Perlis; Ellen B Dennehy; David J Miklowitz; Melissa P DelBello; Michael J Ostacher; Joseph Calabrese; Rebecca M Ametrano; Stephen R Wisniewski; Charles L Bowden; Michael E Thase; Andrew A Nierenberg; Gary Sachs
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar disorders 2009;11(4):391-400.
2009: W. Emanuel Severus; Nikolaus Kleindienst; G Evoniuk; Charles L Bowden; Hans-Jürgen Möller; M Bohus; Sophia Frangou; Waldemar Greil; Joseph Calabrese
Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Journal of affective disorders 2009;115(3):466-70.
2009: Joseph F Goldberg; Roy H Perlis; Charles L Bowden; Michael E Thase; David J Miklowitz; Lauren B Marangell; Joseph Calabrese; Andrew A Nierenberg; Gary S Sachs
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2009;166(2):173-81.
2009: Heinz Grunze; Eduard Vieta; Guy M Goodwin; Charles L Bowden; Rasmus W Licht; Hans-Jurgen Moller; Siegfried Kasper
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(2):85-116.
2008: Mauricio Tohen; Eduard Vieta; Guy M Goodwin; Bin Sun; Jay D Amsterdam; Michael Banov; Anantha Shekhar; Scott Tyler Aaronson; Leonid Bardenstein; Iosif Grecu-Gabos; Vladimir Tochilov; Dan Prelipceanu; Heather S Oliff; Ludmila Kryzhanovskaya; Charles L Bowden
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
The Journal of clinical psychiatry 2008;69(11):1776-89.
2008: Charles L Bowden
Bipolar pathophysiology and development of improved treatments.
Brain research 2008;1235():92-7.
2008: Charles L Bowden; Ahmet Göğüş; Heinz Grunze; Lars Häggström; Janusz Rybakowski; Eduard Vieta
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
International clinical psychopharmacology 2008;23(5):254-62.
2008: Guy M Goodwin; Ian Anderson; Celso Arango; Charles L Bowden; Chantal Henry; Philip B Mitchell; Willem A Nolen; Eduard Vieta; Hans-Ulrich Wittchen
ECNP consensus meeting. Bipolar depression. Nice, March 2007.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(7):535-49.
2008: Fabiano Nery; John P Hatch; David C Glahn; Mark A Nicoletti; E Serap Monkul; Pablo Najt; Manoela Fonseca; Charles L Bowden; C Robert Cloninger; Jair C Soares
Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders.
Journal of psychiatric research 2008;42(7):569-77.
2008: Richard H Weisler; Joseph Calabrese; Charles L Bowden; John A Ascher; Joseph DeVeaugh-Geiss; Gary Evoniuk
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Journal of affective disorders 2008;108(1-2):1-9.
2008: Susan L McElroy; Charles L Bowden; Michelle A Collins; Patricia J Wozniak; Paul E Keck; Joseph Calabrese
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
Journal of affective disorders 2008;107(1-3):127-33.
2008: Fabiano Nery; E Serap Monkul; John P Hatch; Manoela Fonseca; Giovana B Zunta-Soares; Benício N Frey; Charles L Bowden; Jair C Soares
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Human psychopharmacology 2008;23(2):87-94.
2008: Mauricio Tohen; Charles L Bowden; Anatoly B Smulevich; RF Bergstrom; Tonya Quinlan; Olawale Osuntokun; Wei V Wang; Heather S Oliff; Ferenc Martenyi; Ludmila A Kryzhanovskaya; Waldemar Greil
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes.
The British journal of psychiatry : the journal of mental science 2008;192(2):135-43.
2008: Lori Davis; Jonathan R T Davidson; L Charles Ward; Alfred A Bartolucci; Charles L Bowden; Frederick Petty
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
Journal of clinical psychopharmacology 2008;28(1):84-8.
2008: Michael E Thase; Alan Jonas; Arif Khan; Charles L Bowden; Xiaoling Wu; Robert D McQuade; William H Carson; Ronald N Marcus; Randall Owen
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Journal of clinical psychopharmacology 2008;28(1):13-20.
2008: Jodi Gonzalez; Charles L Bowden; Martin M Katz; Peter Thompson; Vivek Singh; Thomas J Prihoda; Martha Dahl
Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability.
International journal of methods in psychiatric research 2008;17(4):198-209.
2008: Charles L Bowden; Suzanne Edwards; Gary Evoniuk
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
CNS spectrums 2008;13(1):75-83.
2008: Joseph F Goldberg; Charles L Bowden; Joseph Calabrese; Terence A Ketter; Rebekkah S Dann; Mark A Frye; Trisha Suppes; Robert M Post
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder.
Biological psychiatry 2008;63(1):125-30.
2007: Mauricio Tohen; Joseph Calabrese; Eduard Vieta; Charles L Bowden; Ana Gonzalez-Pinto; Daniel Lin; Wen Xu; Sara Corya
Effect of comorbid anxiety on treatment response in bipolar depression.
Journal of affective disorders 2007;104(1-3):137-46.
2007: David C Glahn; Carrie E Bearden; Marcela Barguil; Jennifer Barrett; Abraham Reichenberg; Charles L Bowden; Jair C Soares; Dawn I Velligan
The neurocognitive signature of psychotic bipolar disorder.
Biological psychiatry 2007;62(8):910-6.
2007: Benício N Frey; Consuelo Walss-Bass; Jeffrey Stanley; Fabiano Nery; Koji Matsuo; Mark A Nicoletti; John P Hatch; Charles L Bowden; Michael Escamilla; Jair C Soares
Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder.
Neuroreport 2007;18(15):1567-70.
2007: John P Houston; Ilya Lipkovich; Jonna Ahl; Matthew D Rotelli; Robert W Baker; Charles L Bowden
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
Journal of psychiatric research 2007;41(7):616-21.
2007: Joseph F Goldberg; Roy H Perlis; S Nassir Ghaemi; Joseph Calabrese; Charles L Bowden; Stephen R Wisniewski; David J Miklowitz; Gary S Sachs; Michael E Thase
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
The American journal of psychiatry 2007;164(9):1348-55.
2007: Charles L Bowden; Vivek Singh; Peter Thompson; Jodi Gonzalez; Martin M Katz; M Dahl; Thomas J Prihoda; X Chang
Development of the bipolar inventory of symptoms scale.
Acta psychiatrica Scandinavica 2007;116(3):189-94.
2007: M A M Peluso; John P Hatch; David C Glahn; E Serap Monkul; Marsal Sanches; Pablo Najt; Charles L Bowden; E S Barratt; Jair C Soares
Trait impulsivity in patients with mood disorders.
Journal of affective disorders 2007;100(1-3):227-31.
2007: Gary S Sachs; Andrew A Nierenberg; Joseph Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
The New England journal of medicine 2007;356(17):1711-22.
2007: Jodi Gonzalez; Peter Thompson; Michael Escamilla; Mako Araga; Vivek Singh; Niamh Farrelly; Michael E Thase; David J Miklowitz; Charles L Bowden
Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.
Psychopharmacology bulletin 2007;40(1):31-46.
2007: Jodi Gonzalez; Deborah A Perlick; David J Miklowitz; Richard Kaczynski; Melissa Hernandez; Robert A Rosenheck; Jenifer L Culver; Michael J Ostacher; Charles L Bowden
Factors associated with stigma among caregivers of patients with bipolar disorder in the STEP-BD study.
Psychiatric services (Washington, D.C.) 2007;58(1):41-8.
2007: Charles L Bowden
Spectrum of effectiveness of valproate in neuropsychiatry.
Expert review of neurotherapeutics 2007;7(1):9-16.
2006: James R Redmond; Katrina L Jamison; Charles L Bowden
Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
CNS spectrums 2006;11(12):915-8.
2006: Mauricio Tohen; Charles L Bowden; Joseph Calabrese; Daniel Lin; Tammy D Forrester; Gary S Sachs; Athanasios Koukopoulos; Lakshmi N Yatham; Heinz Grunze
Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
The British journal of psychiatry : the journal of mental science 2006;189():515-9.
2006: Martin M Katz; Charles L Bowden; Nancy Berman; Alan Frazer
Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.
Journal of clinical psychopharmacology 2006;26(6):549-53.
2006: Mark A Frye; Lakshmi N Yatham; Joseph Calabrese; Charles L Bowden; Terence A Ketter; Trisha Suppes; Bryan E Adams; Thomas R Thompson
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
The Journal of clinical psychiatry 2006;67(11):1721-8.
2006: Charles L Bowden; Alan C Swann; Joseph Calabrese; Leon M Rubenfaer; Patricia J Wozniak; Michelle A Collins; Walid Abi-Saab; Mario Saltarelli
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
The Journal of clinical psychiatry 2006;67(10):1501-10.
2006: Charles L Bowden; Joseph Calabrese; Terence A Ketter; Gary S Sachs; Robin L White; Thomas R Thompson
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
The American journal of psychiatry 2006;163(7):1199-201.
2006: Charles L Bowden; Vivek Singh
Bipolar disorders: treatment options and patient satisfaction.
Neuropsychiatric disease and treatment 2006;2(2):149-53.
2006: Martin M Katz; Alan Frazer; Charles L Bowden
'Delay' hypothesis of onset of antidepressant action.
The British journal of psychiatry : the journal of mental science 2006;188():586; author reply 587.
2006: David C Glahn; Carrie E Bearden; Charles L Bowden; Jair C Soares
Reduced educational attainment in bipolar disorder.
Journal of affective disorders 2006;92(2-3):309-12.
2006: Martin M Katz; John P Houston; Stephen K Brannan; Janet L Tekell; Nancy Berman; Charles L Bowden; Alan Frazer
A video method for the evaluation of antidepressant clinical and behavioural actions.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(3):327-36.
2006: Charles L Bowden; Nancy U Karren
Anticonvulsants in bipolar disorder.
The Australian and New Zealand journal of psychiatry 2006;40(5):386-93.
2006: Gary Sachs; Charles L Bowden; Joseph Calabrese; Terence A Ketter; Thomas Thompson; Robin White; Beth Bentley
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.
Bipolar disorders 2006;8(2):175-81.
2006: Sheila C Caetano; Rene Olvera; Kristina Hunter; John P Hatch; Pablo Najt; Charles L Bowden; Steven R Pliszka; Jair C Soares
Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients.
Journal of affective disorders 2006;91(1):33-7.
2006: Michael Allen; Robert M A Hirschfeld; Patricia Wozniak; Jeffrey D Baker; Charles L Bowden
Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
The American journal of psychiatry 2006;163(2):272-5.
2006: Mauricio Tohen; Joseph Calabrese; Gary S Sachs; Michael D Banov; Holland C Detke; Richard Risser; Robert W Baker; James C-Y Chou; Charles L Bowden
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
The American journal of psychiatry 2006;163(2):247-56.
2006: Charles L Bowden
Cognitive therapy is more cost effective than standard care alone for bipolar disorder.
Evidence-based mental health 2006;9(1):14.
2006: Carrie E Bearden; David C Glahn; E Serap Monkul; Jennifer Barrett; Pablo Najt; Simerjit Kaur; Marsal Sanches; Veronica Villarreal; Charles L Bowden; Jair C Soares
Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features.
Journal of psychiatric research 2006;40(1):47-58.
2005: Michael Allen; Cheryl A Chessick; David J Miklowitz; Joseph F Goldberg; Stephen R Wisniewski; Sachiko Miyahara; Joseph Calabrese; Lauren B Marangell; Mark S Bauer; Marshall R Thomas; Charles L Bowden; Gary S Sachs
Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts.
Suicide & life-threatening behavior 2005;35(6):671-80.
2005: Charles L Bowden; Terence A Ketter; Gary S Sachs; Michael E Thase
Focus on bipolar disorder treatment.
The Journal of clinical psychiatry 2005;66(12):1598-609.
2005: Joseph F Goldberg; Michael Allen; David A Miklowitz; Charles L Bowden; Carrie J Endick; Cheryl A Chessick; Stephen R Wisniewski; Sachiko Miyahara; Kemal Sagduyu; Michael E Thase; Joseph Calabrese; Gary S Sachs
Suicidal ideation and pharmacotherapy among STEP-BD patients.
Psychiatric services (Washington, D.C.) 2005;56(12):1534-40.
2005: Charles L Bowden; Michelle A Collins; Susan L McElroy; Joseph Calabrese; Alan C Swann; Richard H Weisler; Patricia J Wozniak
Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(10):1932-9.
2005: Trisha Suppes; Ellen B Dennehy; Robert M A Hirschfeld; Lori L Altshuler; Charles L Bowden; Joseph Calabrese; M Lynn Crismon; Terence A Ketter; Gary S Sachs; Alan C Swann
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
The Journal of clinical psychiatry 2005;66(7):870-86.
2005: Mauricio Tohen; Waldemar Greil; Joseph Calabrese; Gary S Sachs; Lakshmi N Yatham; Bruno Müller Oerlinghausen; Athanasios Koukopoulos; Giovanni B Cassano; Heinz Grunze; Rasmus W Licht; Liliana Dell'osso; Angela R Evans; Richard Risser; Robert W Baker; Heidi Crane; Martin Dossenbach; Charles L Bowden
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
The American journal of psychiatry 2005;162(7):1281-90.
2005: Charles L Bowden
Bipolar disorder and work loss.
The American journal of managed care 2005;11(3 Suppl):S91-4.
2005: Roger D Weiss; Michael J Ostacher; Michael W Otto; Joseph Calabrese; Mark D Fossey; Stephen R Wisniewski; Charles L Bowden; Andrew A Nierenberg; Mark H Pollack; Ihsan Salloum; Naomi M Simon; Michael E Thase; Gary S Sachs
Does recovery from substance use disorder matter in patients with bipolar disorder?
The Journal of clinical psychiatry 2005;66(6):730-5; quiz 808-9.
2005: Pablo Najt; David C Glahn; Carrie E Bearden; John P Hatch; E Serap Monkul; Simerjit Kaur; Veronica Villarreal; Charles L Bowden; Jair C Soares
Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test.
Neuroscience letters 2005;379(2):122-6.
2005: Charles L Bowden
A different depression: clinical distinctions between bipolar and unipolar depression.
Journal of affective disorders 2005;84(2-3):117-25.
2005: Hader A Mansour; Michael E Talkowski; Joel Wood; Lora Pless; Mikhil Bamne; Kodavali V Chowdari; Michael Allen; Charles L Bowden; Joseph Calabrese; Rif S el-Mallakh; Andrea Fagiolini; Stephen Faraone; Mark D Fossey; Edward S Friedman; Laszlo Gyulai; Peter Hauser; Terence A Ketter; Jennifer M Loftis; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Michael E Thase; Ellen Frank; David J Kupfer; Vishwajit L Nimgaonkar
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Annals of medicine 2005;37(8):590-602.
2005: Lakshmi N Yatham; Jeffrey M Goldstein; Eduard Vieta; Charles L Bowden; Heinz Grunze; Robert M Post; Trisha Suppes; Joseph Calabrese
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
The Journal of clinical psychiatry 2005;66 Suppl 5():40-8.
2005: Charles L Bowden
Introduction: the burden of bipolar depression.
The Journal of clinical psychiatry 2005;66 Suppl 5():3-4.
2005: Joseph Calabrese; Paul E Keck; Charles L Bowden; Terence A Ketter; Gary Sachs; Robert L Findling; Martha Sajatovic
A US perspective of the CANMAT bipolar guidelines.
Bipolar disorders 2005;7 Suppl 3():70-2.
2005: Charles L Bowden; Vivek Singh
Valproate in bipolar disorder: 2000 onwards.
Acta psychiatrica Scandinavica. Supplementum 2005;(426):13-20.
2005: Charles L Bowden
Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
The Journal of clinical psychiatry 2005;66 Suppl 3():12-9.
2005: Charles L Bowden
Treatment options for bipolar depression.
The Journal of clinical psychiatry 2005;66 Suppl 1():3-6.
2005: Charles L Bowden; Heinz Grunze; Jamie Mullen; Martin Brecher; Björn Paulsson; Martin Jones; Mårten Vågerö; K Svensson
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
The Journal of clinical psychiatry 2005;66(1):111-21.
2004: Charles L Bowden
Relationship of acute mania symptomatology to maintenance treatment response.
Current psychiatry reports 2004;6(6):473-7.
2004: Martin M Katz; John P Houston; Stephen K Brannan; Charles L Bowden; Nancy Berman; Alan C Swann; Alan Frazer
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):471-9.
2004: Charles P O'Brien; Dennis S Charney; Lydia Lewis; James W Cornish; Robert M Post; George E Woody; Jon K Zubieta; James C Anthony; Jack D Blaine; Charles L Bowden; Joseph Calabrese; Kathleen Carroll; Thomas Kosten; Bruce Rounsaville; Anna Rose Childress; David W Oslin; Helen M Pettinati; Mark A Davis; Robert Demartino; Robert E Drake; Michael F Fleming; Larry Fricks; Alexander H Glassman; Frances R Levin; Edward V Nunes; Robert L Johnson; Clarence Jordan; Ronald C Kessler; Sally K Laden; Darrel A Regier; John A Renner; Richard K Ries; Thomas Sklar-Blake; Constance Weisner
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action.
Biological psychiatry 2004;56(10):703-13.
2004: Christopher D Schneck; David J Miklowitz; Joseph Calabrese; Michael Allen; Marshall R Thomas; Stephen R Wisniewski; Sachiko Miyahara; Melvin D Shelton; Terence A Ketter; Joseph F Goldberg; Charles L Bowden; Gary S Sachs
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
The American journal of psychiatry 2004;161(10):1902-8.
2004: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; Hans-Jürgen Möller
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):120-35.
2004: Charles L Bowden; Joyce E Myers; Fred Grossman; Yang Xie
Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
The Journal of clinical psychiatry 2004;65(5):707-14.
2004: Charles L Bowden; Anupama A Krishnan
Pharmacotherapy for bipolar depression: an economic assessment.
Expert opinion on pharmacotherapy 2004;5(5):1101-7.
2004: Roy H Perlis; Sachiko Miyahara; Lauren B Marangell; Stephen R Wisniewski; Michael J Ostacher; Melissa P DelBello; Charles L Bowden; Gary S Sachs; Andrew A Nierenberg
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2004;55(9):875-81.
2004: Charles L Bowden
The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
Journal of affective disorders 2004;79 Suppl 1():S9-14.
2004: Mauricio Tohen; K N Roy Chengappa; Trisha Suppes; Robert W Baker; Carlos A Zarate; Charles L Bowden; Gary S Sachs; David J Kupfer; S Nassir Ghaemi; Peter Feldman; Richard Risser; Angela R Evans; Joseph Calabrese
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
The British journal of psychiatry : the journal of mental science 2004;184():337-45.
2004: Lauren B Marangell; James M Martinez; Terence A Ketter; Charles L Bowden; Joseph F Goldberg; Joseph Calabrese; Sachiko Miyahara; David J Miklowitz; Gary S Sachs; Michael E Thase
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Bipolar disorders 2004;6(2):139-43.
2004: Guy M Goodwin; Charles L Bowden; Joseph Calabrese; Heinz Grunze; Siegfried Kasper; Robin White; Paul Greene; Robert Leadbetter
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
The Journal of clinical psychiatry 2004;65(3):432-41.
2004: Martin M Katz; Janet L Tekell; Charles L Bowden; Stephen K Brannan; John P Houston; Nancy Berman; Alan Frazer
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(3):566-79.
2004: Charles L Bowden; Jan Fawcett
Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder.
JAMA : the journal of the American Medical Association 2004;291(8):939; author reply 940.
2004: Charles L Bowden
Making optimal use of combination pharmacotherapy in bipolar disorder.
The Journal of clinical psychiatry 2004;65 Suppl 15():21-4.
2004: Charles L Bowden
Introduction: managing bipolar depression.
The Journal of clinical psychiatry 2004;65 Suppl 10():3-4.
2004: Charles L Bowden; Gregory M Asnis; Lawrence D Ginsberg; Beth Bentley; Robert Leadbetter; Robin White
Safety and tolerability of lamotrigine for bipolar disorder.
Drug safety : an international journal of medical toxicology and drug experience 2004;27(3):173-84.
2003: Mauricio Tohen; Eduard Vieta; Joseph Calabrese; Terence A Ketter; Gary Sachs; Charles L Bowden; Philip B Mitchell; Franca Centorrino; Richard Risser; Robert W Baker; Angela R Evans; Karin Beymer; Sanjay Dube; Gary D Tollefson; Alan Breier
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Archives of general psychiatry 2003;60(11):1079-88.
2003: Joseph Calabrese; Charles L Bowden; Gary Sachs; Lakshmi N Yatham; Kirsten Behnke; Olli-Pekka Mehtonen; Paul Montgomery; John Ascher; Walter Paska; Nancy Earl; Joseph DeVeaugh-Geiss
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
The Journal of clinical psychiatry 2003;64(9):1013-24.
2003: Charles L Bowden
Acute and maintenance treatment with mood stabilizers.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(3):269-75.
2003: Laszlo Gyulai; Charles L Bowden; Susan L McElroy; Joseph Calabrese; Frederick Petty; Alan C Swann; James C-Y Chou; Adel Wassef; Craig S Risch; Robert M A Hirschfeld; Charles Nemeroff; Paul E Keck; Dwight L Evans; Patricia J Wozniak
Maintenance efficacy of divalproex in the prevention of bipolar depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(7):1374-82.
2003: Gary S Sachs; Michael E Thase; Michael W Otto; Mark Bauer; David J Miklowitz; Stephen R Wisniewski; Philip W Lavori; Barry Lebowitz; Matthew V Rudorfer; Ellen Frank; Andrew A Nierenberg; Maurizio Fava; Charles L Bowden; Terence A Ketter; Lauren B Marangell; Joseph Calabrese; David Kupfer; Jerrold F Rosenbaum
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Charles L Bowden
Valproate.
Bipolar disorders 2003;5(3):189-202.
2003: Bankole A Johnson; Nassima Ait-Daoud; Charles L Bowden; Carlo C Diclemente; John D Roache; Kevin Lawson; Martin A Javors; Jennie Z Ma
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Lancet 2003;361(9370):1677-85.
2003: Charles L Bowden; Joseph Calabrese; Gary Sachs; Lakshmi N Yatham; Shaheen Akthar Asghar; Magne Hompland; Paul Montgomery; Nancy Earl; Tonya M Smoot; Joseph DeVeaugh-Geiss
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Archives of general psychiatry 2003;60(4):392-400.
2003: Charles L Bowden
Improving identification of treatment effectiveness in bipolar disorders.
Bipolar disorders 2003;5(2):77-8.
2003: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(1):5-13.
2003: Todd M Sanger; Mauricio Tohen; Eduard Vieta; David L Dunner; Charles L Bowden; Joseph Calabrese; Peter Feldman; Thomas G Jacobs; Alan Breier
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.
Journal of affective disorders 2003;73(1-2):155-61.
2002: Joseph Calabrese; John R Sullivan; Charles L Bowden; Trisha Suppes; Joseph F Goldberg; Gary S Sachs; Melvin D Shelton; Frederick K Goodwin; Mark A Frye; Vivek Kusumakar
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
The Journal of clinical psychiatry 2002;63(11):1012-9.
2002: Charles L Bowden
Lamotrigine in the treatment of bipolar disorder.
Expert opinion on pharmacotherapy 2002;3(10):1513-9.
2002: Karen Dineen Wagner; Elizabeth B Weller; Gabrielle A Carlson; Gary Sachs; Joseph Biederman; Jean A Frazier; Patricia Wozniak; Katherine A Tracy; Ronald A Weller; Charles L Bowden
An open-label trial of divalproex in children and adolescents with bipolar disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(10):1224-30.
2002: Martin M Katz; Uriel Halbreich; Charles L Bowden; Alan Frazer; Roger M Pinder; A John Rush; David P Wheatley; Barry D Lebowitz
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(3):319-28.
2002: Charles L Bowden
Diagnosis of bipolar disorders: focus on bipolar disorder I and bipolar disorder II.
MedGenMed : Medscape general medicine 2002;4(3):17.
2002: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(3):115-24.
2002: Gary S Sachs; Fred Grossman; S Nassir Ghaemi; Akiko Okamoto; Charles L Bowden
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
The American journal of psychiatry 2002;159(7):1146-54.
2002: Trisha Suppes; Ellen B Dennehy; Alan C Swann; Charles L Bowden; Joseph Calabrese; Robert M A Hirschfeld; Paul E Keck; Gary S Sachs; M Lynn Crismon; Marcia G Toprac; Steven P Shon
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.
The Journal of clinical psychiatry 2002;63(4):288-99.
2002: Alan C Swann; Charles L Bowden; Joseph Calabrese; Steven C Dilsaver; David D Morris
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(4):530-6.
2002: Dennis S Charney; Charles Nemeroff; Lydia Lewis; Sally K Laden; Jack M Gorman; Eugene M Laska; Michael Borenstein; Charles L Bowden; Arthur Caplan; Graham J Emslie; Dwight L Evans; Barbara Geller; Lenore E Grabowski; Jay Herson; Ned H Kalin; Paul E Keck; Irving Kirsch; K Ranga R Krishnan; David J Kupfer; Robert W Makuch; Franklin G Miller; Herbert Pardes; Robert Post; Mildred M Reynolds; Laura Roberts; Jerrold F Rosenbaum; Donald Rosenstein; David Rubinow; john rush; Neal D Ryan; Gary S Sachs; Alan F Schatzberg; Susan Solomon
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Archives of general psychiatry 2002;59(3):262-70.
2002: Mauricio Tohen; K N Roy Chengappa; Trisha Suppes; Carlos A Zarate; Joseph Calabrese; Charles L Bowden; Gary S Sachs; David J Kupfer; Robert W Baker; Richard Risser; Elisabeth L Keeter; Peter Feldman; Gary D Tollefson; Alan Breier
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Archives of general psychiatry 2002;59(1):62-9.
2001: Charles L Bowden
Clinical correlates of therapeutic response in bipolar disorder.
Journal of affective disorders 2001;67(1-3):257-65.
2001: Alan C Swann; P L Janicak; Joseph Calabrese; Charles L Bowden; Steven C Dilsaver; David D Morris; Frederick Petty; John M Davis
Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.
Journal of affective disorders 2001;67(1-3):123-32.
2001: Charles L Bowden
A study about late age onset depression.
Acta psychiatrica Scandinavica 2001;103(6):409-10.
2001: Charles Nemeroff; Dwight L Evans; Laszlo Gyulai; Gary S Sachs; Charles L Bowden; IP Gergel; R Oakes; Cornelius D Pitts
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
The American journal of psychiatry 2001;158(6):906-12.
2001: Charles L Bowden
Novel treatments for bipolar disorder.
Expert opinion on investigational drugs 2001;10(4):661-71.
2001: Joseph Calabrese; Melvin D Shelton; Charles L Bowden; Daniel J Rapport; Trisha Suppes; E R Shirley; Susan E Kimmel; S J Caban
Bipolar rapid cycling: focus on depression as its hallmark.
The Journal of clinical psychiatry 2001;62 Suppl 14():34-41.
2001: Charles L Bowden
Introduction: the role of anticonvulsants as mood stabilizers.
The Journal of clinical psychiatry 2001;62 Suppl 14():3-4.
2001: Charles L Bowden
Strategies to reduce misdiagnosis of bipolar depression.
Psychiatric services (Washington, D.C.) 2001;52(1):51-5.
2000: Charles L Bowden
The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.
Current psychiatry reports 2000;2(6):490-4.
2000: Joseph Calabrese; Trisha Suppes; Charles L Bowden; Gary S Sachs; A C Swann; Susan L McElroy; Vivek Kusumakar; John A Ascher; Nancy Earl; P L Greene; E T Monaghan
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
The Journal of clinical psychiatry 2000;61(11):841-50.
2000: Charles L Bowden; Y Lecrubier; M Bauer; G Goodwin; W Greil; G Sachs
Maintenance therapies for classic and other forms of bipolar disorder.
Journal of affective disorders 2000;59 Suppl 1():S57-S67.
2000: Stephen L Stern; N A Votolato; John P Hatch; Charles L Bowden
The newer antidepressants.
Psychiatric services (Washington, D.C.) 2000;51(8):1051-2.
2000: Alan C Swann; Charles L Bowden; Joseph Calabrese; Steven C Dilsaver; David D Morris
Mania: differential effects of previous depressive and manic episodes on response to treatment.
Acta psychiatrica Scandinavica 2000;101(6):444-51.
2000: Charles L Bowden; Joseph Calabrese; Susan L McElroy; Laszlo Gyulai; A Wassef; Frederick Petty; H G Pope; J C Chou; Paul E Keck; LJ Rhodes; Alan C Swann; Robert M A Hirschfeld; Patricia J Wozniak
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Archives of general psychiatry 2000;57(5):481-9.
2000: Charles L Bowden
Efficacy of lithium in mania and maintenance therapy of bipolar disorder.
The Journal of clinical psychiatry 2000;61 Suppl 9():35-40.
1999: Alan C Swann; Frederick Petty; Charles L Bowden; Steven C Dilsaver; Joseph Calabrese; David D Morris
Mania: gender, transmitter function, and response to treatment.
Psychiatry research 1999;88(1):55-61.
1999: Charles L Bowden
"A two-illness model of bipolar disorder"--by RT Joffe, LT Young, and GM MacQueen: a commentary.
Bipolar disorders 1999;1(1):31-5.
1999: Charles L Bowden; P Mitchell; Trisha Suppes
Lamotrigine in the treatment of bipolar depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9 Suppl 4():S113-7.
1999: Alan C Swann; Charles L Bowden; Joseph Calabrese; Steven C Dilsaver; David D Morris
Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
The American journal of psychiatry 1999;156(8):1264-6.
1999: Joseph Calabrese; Charles L Bowden; Susan L McElroy; John Cookson; J Andersen; Paul E Keck; L Rhodes; Carolyn Bolden-Watson; J Zhou; John A Ascher
Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
The American journal of psychiatry 1999;156(7):1019-23.
1999: Alan C Swann; Martin M Katz; Charles L Bowden; N G Berman; P E Stokes
Psychomotor performance and monoamine function in bipolar and unipolar affective disorders.
Biological psychiatry 1999;45(8):979-88.
1999: Charles L Bowden; Joseph Calabrese; Susan L McElroy; LJ Rhodes; Paul E Keck; John Cookson; J Anderson; Carolyn Bolden-Watson; John A Ascher; E Monaghan; J Zhou
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.
Biological psychiatry 1999;45(8):953-8.
1999: Barnett S Meyers; George S Alexopoulos; Tatsu Kakuma; F Tirumalasetti; Michelle Gabriele; S Alpert; Charles L Bowden; Herbert Y Meltzer
Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.
Biological psychiatry 1999;45(4):448-52.
1999: Joseph Calabrese; Charles L Bowden; Gary S Sachs; John A Ascher; E Monaghan; G D Rudd
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
The Journal of clinical psychiatry 1999;60(2):79-88.
1999: Charles L Bowden
Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
The Journal of clinical psychiatry 1999;60 Suppl 5():3-4.
1998: PJ Goodnick; Roberto Dominguez; C Lindsay DeVane; Charles L Bowden
Bupropion slow-release response in depression: diagnosis and biochemistry.
Biological psychiatry 1998;44(7):629-32.
1998: Charles L Bowden
New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(3):194-9.
1998: A Siafaka-Kapadai; M Patiris; Charles L Bowden; Martin A Javors
Incorporation of [3H]valproic acid into lipids in GT1-7 neurons.
Biochemical pharmacology 1998;56(2):207-12.
1998: Charles L Bowden
Key treatment studies of lithium in manic-depressive illness: efficacy and side effects.
The Journal of clinical psychiatry 1998;59 Suppl 6():13-9; discussion 20.
1997: Charles L Bowden; J Dickson
Mania from dexfenfluramine.
The Journal of clinical psychiatry 1997;58(12):548-9.
1997: Jerrold F Rosenbaum; G Moroz; Charles L Bowden
Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.
Journal of clinical psychopharmacology 1997;17(5):390-400.
1997: Martin M Katz; Charles L Bowden; P Stokes; R Casper; Alan Frazer; S H Koslow; J Kocsis; S Secunda; A Swann; Nancy Berman
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(2):110-5.
1997: A C Swann; Charles L Bowden; A John Rush; Howard M Rhoades; R Rose; R Kobes
Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
Journal of clinical psychopharmacology 1997;17(2):78-83.
1997: Charles L Bowden; Alan C Swann; Joseph Calabrese; Susan L McElroy; D Morris; Frederick Petty; Robert M A Hirschfeld; Laszlo Gyulai
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study.
Psychopharmacology bulletin 1997;33(4):693-9.
1997: Charles L Bowden; John M Davis; D Morris; A Swann; Joseph Calabrese; M Lambert; P Goodnick
Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania.
Depression and anxiety 1997;6(1):26-30.
1997: J A Silva; Janet L Tekell; G Penny; Charles L Bowden
Resolution of palinopsia with carbamazepine.
The Journal of clinical psychiatry 1997;58(1):30.
1997: J W Maas; Charles L Bowden; Alexander Miller; Martin A Javors; L G Funderburg; N Berman; Susan Weintraub
Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.
Schizophrenia bulletin 1997;23(1):147-54.
1997: Alan C Swann; Charles L Bowden; D Morris; Joseph Calabrese; Frederick Petty; J Small; Steven C Dilsaver; John M Davis
Depression during mania. Treatment response to lithium or divalproex.
Archives of general psychiatry 1997;54(1):37-42.
1996: Janet L Tekell; J Arturo Silva; J A Maas; Charles L Bowden; T Starck
Thioridazine-induced retinopathy.
The American journal of psychiatry 1996;153(9):1234-5.
1996: Charles L Bowden; P G Janicak; P Orsulak; Alan C Swann; John M Davis; Joseph Calabrese; P Goodnick; J G Small; A John Rush; Susan E Kimmel; S C Risch; D D Morris
Relation of serum valproate concentration to response in mania.
The American journal of psychiatry 1996;153(6):765-70.
1996: Charles L Bowden
Role of newer medications for bipolar disorder.
Journal of clinical psychopharmacology 1996;16(2 Suppl 1):48S-55S.
1996: Frederick Petty; A John Rush; John M Davis; Joseph Calabrese; Susan E Kimmel; Gerald L Kramer; J G Small; M J Miller; A E Swann; P J Orsulak; M E Blake; Charles L Bowden
Plasma GABA predicts acute response to divalproex in mania.
Biological psychiatry 1996;39(4):278-84.
1996: Charles L Bowden
Dosing strategies and time course of response to antimanic drugs.
The Journal of clinical psychiatry 1996;57 Suppl 13():4-9; discussion 10-2.
1995: J W Maas; Alexander Miller; Janet L Tekell; L Funderburg; J Arturo Silva; J True; Dawn I Velligan; N Berman; Charles L Bowden
Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.
Journal of clinical psychopharmacology 1995;15(5):361-4.
1995: J Arturo Silva; Janet L Tekell; Gregory B Leong; Charles L Bowden
Delusional misidentification of the self associated with nondominant cerebral pathology.
The Journal of clinical psychiatry 1995;56(4):171.
1995: S Gabel; J Stadler; J Bjorn; R Schindledecker; Charles L Bowden
Homovanillic acid and monoamine oxidase in sons of substance-abusing fathers: relationship to conduct disorder.
Journal of studies on alcohol 1995;56(2):135-9.
1995: J Arturo Silva; Gregory B Leong; Janet L Tekell; Charles L Bowden
Visual-perceptual disturbances in delusional misidentification.
The Israel journal of psychiatry and related sciences 1995;32(4):286-90.
1995: Charles L Bowden; S L McElroy
History of the development of valproate for treatment of bipolar disorder.
The Journal of clinical psychiatry 1995;56 Suppl 3():3-5.
1995: Charles L Bowden
Predictors of response to divalproex and lithium.
The Journal of clinical psychiatry 1995;56 Suppl 3():25-30.
1995: Charles L Bowden; Joseph Calabrese; B A Wallin; A C Swann; S L McElroy; S C Risch; M A Hirschfeld
Illness characteristics of patients in clinical drug studies of mania.
Psychopharmacology bulletin 1995;31(1):103-9.
1994: J Arturo Silva; Gregory B Leong; E S Garza-Treviño; J Le Grand; D Oliva; Robert Weinstock; Charles L Bowden
A cognitive model of dangerous delusional misidentification syndromes.
Journal of forensic sciences 1994;39(6):1455-67.
1994: Naomi Breslau; Kathleen Ries Merikangas; Charles L Bowden
Comorbidity of migraine and major affective disorders.
Neurology 1994;44(10 Suppl 7):S17-22.
1994: S Gabel; J Stadler; J Bjorn; R Shindledecker; Charles L Bowden
Monoamine oxidase and homovanillic acid in boys with predispositions to substance abuse.
Alcoholism, clinical and experimental research 1994;18(5):1137-42.
1994: Martin M Katz; J W Maas; Alan Frazer; S H Koslow; Charles L Bowden; N Berman; Alan C Swann; P E Stokes
Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(2):89-100.
1994: Regina C Casper; Martin M Katz; Charles L Bowden; John M Davis; S H Koslow; I Hanin
The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.
Journal of affective disorders 1994;31(3):151-64.
1994: J W Maas; Martin M Katz; S H Koslow; Alan Swann; John M Davis; N Berman; Charles L Bowden; P E Stokes; H Landis
Adrenomedullary function in depressed patients.
Journal of psychiatric research 1994;28(4):357-67.
1994: Alan C Swann; P E Stokes; S K Secunda; J W Maas; Charles L Bowden; N Berman; S H Koslow
Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
Biological psychiatry 1994;35(10):803-13.
1994: S K Brannan; B J Talley; Charles L Bowden
Sertraline and isocarboxazid cause a serotonin syndrome.
Journal of clinical psychopharmacology 1994;14(2):144-5.
1994: Charles L Bowden; A M Brugger; Alan C Swann; Joseph Calabrese; P G Janicak; Frederick Petty; Steven C Dilsaver; John M Davis; A John Rush; J G Small
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
JAMA : the journal of the American Medical Association 1994;271(12):918-24.
1994: S Gabel; J Stadler; J Bjorn; R Shindledecker; Charles L Bowden
Sensation seeking in psychiatrically disturbed youth: relationship to biochemical parameters and behavior problems.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(1):123-9.
1993: S Gabel; J Stadler; J Bjorn; R Shindledecker; Charles L Bowden
Dopamine-beta-hydroxylase in behaviorally disturbed youth. Relationship between teacher and parent ratings.
Biological psychiatry 1993;34(7):434-42.
1993: Charles L Bowden; Alan F Schatzberg; A Rosenbaum; S A Contreras; J A Samson; E Dessain; M Sayler
Fluoxetine and desipramine in major depressive disorder.
Journal of clinical psychopharmacology 1993;13(5):305-11.
1993: Alexander Miller; J W Maas; S Contreras; E Seleshi; J E True; Charles L Bowden; J Castiglioni
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Biological psychiatry 1993;34(3):178-87.
1993: Alan C Swann; S K Secunda; Martin M Katz; J Croughan; Charles L Bowden; S H Koslow; N Berman; P E Stokes
Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression.
Journal of affective disorders 1993;28(2):81-9.
1993: J W Maas; S A Contreras; Alexander Miller; N Berman; Charles L Bowden; Martin A Javors; E Seleshi; Susan Weintraub
Studies of catecholamine metabolism in schizophrenia/psychosis--I.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):97-109.
1993: J W Maas; S A Contreras; Alexander Miller; N Berman; Charles L Bowden; Martin A Javors; E Seleshi; Susan Weintraub
Studies of catecholamine metabolism in schizophrenia/psychosis--II.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):111-6.
1993: S Gabel; J Stadler; J Bjorn; R Shindledecker; Charles L Bowden
Biodevelopmental aspects of conduct disorder in boys.
Child psychiatry and human development 1993;24(2):125-41.
1992: Alan C Swann; P E Stokes; R Casper; S K Secunda; Charles L Bowden; N Berman; Martin M Katz; E Robins
Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
Acta psychiatrica Scandinavica 1992;85(4):270-4.
1992: William Z Potter; Charles L Bowden
Valproate and mood disorders: perspectives. Introduction.
Journal of clinical psychopharmacology 1992;12(1 Suppl):2S-6S.
1992: Charles L Bowden
Psychopharmacological treatment of panic disorder.
Bulletin of the Menninger Clinic 1992;56(2 Suppl A):A29-41.
1992: JJ Schildkraut; Alan F Schatzberg; J A Samson; A Rosenbaum; Charles L Bowden
Norepinephrine output and metabolism in depressed patients during antidepressant treatments.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():323A-324A.
1992: Charles L Bowden
Implications of psychopharmacological studies for the practice of psychoanalysis.
The Journal of the American Academy of Psychoanalysis 1992;20(3):477-86.
1991: Martin M Katz; S H Koslow; J W Maas; Alan Frazer; J Kocsis; S Secunda; Charles L Bowden; Regina C Casper
Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression.
Psychological medicine 1991;21(3):599-611.
1991: Alan C Swann; S K Secunda; S H Koslow; Martin M Katz; Charles L Bowden; J W Maas; John M Davis; E Robins
Mania: sympathoadrenal function and clinical state.
Psychiatry research 1991;37(2):195-205.
1990: Martin A Javors; M Liu; B S Cuvelier; Charles L Bowden
Characterization of the effect of the adenosine agonist cyclohexyladenosine on platelet activating factor-induced increases in [Ca2+]i in human platelets in vitro.
Cell calcium 1990;11(10):647-53.
1990: Charles L Bowden
Clinical management of anxiety.
Hospital practice (Office ed.) 1990;25 Suppl 2():19-27; discussion 28-30.
1990: James H Kocsis; J L Croughan; Martin M Katz; T P Butler; S Secunda; Charles L Bowden; John M Davis
Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
The American journal of psychiatry 1990;147(5):621-4.
1990: C H Tan; Martin A Javors; E Seleshi; P A Lowrimore; Charles L Bowden
Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls.
Life sciences 1990;46(16):1175-80.
1989: Charles L Bowden; E Seleshi; Martin A Javors
Mania associated with high percentage of inhibition of monoamine oxidase.
The American journal of psychiatry 1989;146(1):121.
1989: Martin A Javors; M E Bembenek; Charles L Bowden; Creed W Abell; J W Maas
The effect of debrisoquin on MAO A and MAO B activities.
Life sciences 1989;45(24):2359-64.
1988: S A Contreras; J W Maas; E Seleshi; Charles L Bowden
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Biological psychiatry 1988;24(7):818-22.
1988: Charles L Bowden; Alexander Miller; E Seleshi
New developments in the treatment of anxiety disorders.
Texas medicine 1988;84(9):38-42.
1988: John M Davis; S H Koslow; Robert D Gibbons; J W Maas; Charles L Bowden; R Casper; I Hanin; Javaid I Javaid; S S Chang; P E Stokes
Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
Archives of general psychiatry 1988;45(8):705-17.
1988: J W Maas; S A Contreras; E Seleshi; Charles L Bowden
Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Archives of general psychiatry 1988;45(6):553-9.
1988: Charles L Bowden; Curtis K Deutsch; J M Swanson
Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1988;27(2):171-4.
1988: Charles L Bowden; L G Huang; Martin A Javors; J M Johnson; E Seleshi; K McIntyre; S Contreras; J W Maas
Calcium function in affective disorders and healthy controls.
Biological psychiatry 1988;23(4):367-76.
1987: S A Contreras; J W Maas; E Seleshi; Charles L Bowden
Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration.
Archives of general psychiatry 1987;44(12):1109-10.
1987: P C Mohl; L Huang; Charles L Bowden; Michael Fischbach; K Vogtsberger; N Talal
Natural killer cell activity in major depression.
The American journal of psychiatry 1987;144(12):1619.
1987: Martin M Katz; S H Koslow; J W Maas; Alan Frazer; Charles L Bowden; R Casper; J Croughan; J Kocsis; E Redmond
The timing, specificity and clinical prediction of tricyclic drug effects in depression.
Psychological medicine 1987;17(2):297-309.
1987: S Contreras; H Alexander; R Faber; Charles L Bowden
Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
Journal of clinical psychopharmacology 1987;7(2):95-8.
1987: J W Maas; S H Koslow; John M Davis; M Katz; Alan Frazer; Charles L Bowden; N Berman; Robert D Gibbons; P Stokes; D H Landis
Catecholamine metabolism and disposition in healthy and depressed subjects.
Archives of general psychiatry 1987;44(4):337-44.
1987: Martin A Javors; G Blaisdell; J Lee; Charles L Bowden
Binding of imipramine to platelet membranes is lower in alcoholics than in controls.
Alcohol and drug research 1987;7(5-6):453-9.
1987: R W Sommi; M L Crismon; Charles L Bowden
Fluoxetine: a serotonin-specific, second-generation antidepressant.
Pharmacotherapy 1987;7(1):1-15.
1987: Martin A Javors; Charles L Bowden
The human platelet as a model for calcium metabolism in central nerve endings in the study of alcoholism.
Alcohol and drug research 1987;7(5-6):311-9.
1987: Charles L Bowden; S Koslow; J W Maas; John M Davis; D L Garver; I Hanin
Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine.
Journal of psychiatric research 1987;21(2):111-28.
1986: J P Houston; J W Maas; Charles L Bowden; S A Contreras; K L McIntyre; Martin A Javors
Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Psychiatry research 1986;19(3):207-14.
1986: S H Koslow; J W Maas; Charles L Bowden; John M Davis; I Hanin; J Javaid
Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
Archives of general psychiatry 1986;43(10):1012-3.
1986: Irwin Russell; G A Vipraio; William Morgan; Charles L Bowden
Is there a metabolic basis for the fibrositis syndrome?
The American journal of medicine 1986;81(3A):50-4.
1986: Robert D Gibbons; J W Maas; John M Davis; A C Swann; D E Redmond; Regina C Casper; I Hanin; Charles L Bowden; J Kocsis; P E Stokes
Path analysis of psychopharmacological data: catecholamine breakdown in man.
Psychiatry research 1986;18(1):89-105.
1986: J B Cohn; Charles L Bowden; J G Fisher; J J Rodos
Double-blind comparison of buspirone and clorazepate in anxious outpatients.
The American journal of medicine 1986;80(3B):10-6.
1986: James H Kocsis; I Hanin; Charles L Bowden; D Brunswick
Imipramine and amitriptyline plasma concentrations and clinical response in major depression.
The British journal of psychiatry : the journal of mental science 1986;148():52-7.
1985: Charles L Bowden
Current treatment of depression.
Hospital & community psychiatry 1985;36(11):1192-200.
1985: Alexander Miller; Charles L Bowden; J Plewes
Lithium and impairment of renal concentrating ability.
Journal of affective disorders 1985;9(2):115-9.
1985: I Hanin; S H Koslow; James H Kocsis; Charles L Bowden; D Brunswick; Alan Frazer; J Carl; E Robins
Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome.
Journal of affective disorders 1985;9(1):69-78.
1985: J W Maas; S A Contreras; Charles L Bowden; Susan Weintraub
Effects of debrisoquin on CSF and plasma HVA concentrations in man.
Life sciences 1985;36(22):2163-70.
1985: Martin A Javors; J P Houston; Charles L Bowden
EGTA-extractable calmodulin in platelet membrane is lower in alcoholics than in controls.
Alcohol (Fayetteville, N.Y.) 1985;2(3):433-6.
1985: Michael W Jann; L Ereshefsky; Stephen Saklad; D R Seidel; C M Davis; N R Burch; Charles L Bowden
Effects of carbamazepine on plasma haloperidol levels.
Journal of clinical psychopharmacology 1985;5(2):106-9.
1985: Charles L Bowden; S H Koslow; I Hanin; J W Maas; John M Davis; E Robins
Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Clinical pharmacology and therapeutics 1985;37(3):316-24.
1985: J P Houston; Martin A Javors; Charles L Bowden
Non-specific neuroleptic isomer effect on calmodulin-stimulated calcium transport in erythrocyte membrane.
Neurochemistry international 1985;7(5):755-60.
1984: Martin A Javors; Charles L Bowden; J W Maas
3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
Journal of chromatography 1984;336(2):259-69.
1984: L G Huang; Charles L Bowden
Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
Journal of clinical psychopharmacology 1984;4(6):326-31.
1984: J W Maas; S H Koslow; Martin M Katz; Charles L Bowden; Robert D Gibbons; P E Stokes; E Robins; John M Davis
Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
The American journal of psychiatry 1984;141(10):1159-71.
1984: Charles L Bowden
Tranylcypromine and inhibition of MAO activity.
Journal of clinical psychopharmacology 1984;4(3):172-3.
1983: Charles L Bowden; W H Sledge; F J Humphrey; M Kromer
Educational objectives in psychiatric residency training: a survey of training directors and residents.
The American journal of psychiatry 1983;140(10):1352-5.
1983: S H Koslow; J W Maas; Charles L Bowden; John M Davis; I Hanin; J Javaid
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Archives of general psychiatry 1983;40(9):999-1010.
1983: Alan Frazer; T A Ramsey; Alan Swann; Charles L Bowden; D Brunswick; D Garver; S Secunda
Plasma and erythrocyte electrolytes in affective disorders.
Journal of affective disorders 1983;5(2):103-13.
1982: Martin A Javors; Charles L Bowden; D H Ross
Kinetic characterization and substrate requirement for the Ca2+ uptake system in platelet membrane.
Biochimica et biophysica acta 1982;691(2):220-6.
1982: Charles L Bowden; J G Fisher
Relationship of diazepam serum level to antianxiety effects.
Journal of clinical psychopharmacology 1982;2(2):110-4.
1982: J W Maas; J H Kocsis; Charles L Bowden; John M Davis; D E Redmond; I Hanin; E Robins
Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
Psychological medicine 1982;12(1):37-43.
1982: Charles L Bowden; J P Houston; R S Shulman; J M Clothier
Clinical utility of salivary lithium concentration.
International pharmacopsychiatry 1982;17(2):104-13.
1982: L S Lehmann; Charles L Bowden; F C Redmond; B C Stanton
Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
Psychopharmacology 1982;77(2):193-7.
1981: Martin A Javors; Charles L Bowden; D H Ross
Kinetic characterization of Ca2+ transport in synaptic membranes.
Journal of neurochemistry 1981;37(2):381-7.
1981: Charles L Bowden; D E Redmond; Alan Swann; J W Maas
Pretreatment amine neurotransmitter system interrelationships in depression [proceedings].
Psychopharmacology bulletin 1981;17(1):70-2.
1980: Charles L Bowden; J G Fisher
Safety and efficacy of long-term diazepam therapy.
Southern medical journal 1980;73(12):1581-4.
1980: J W Maas; S H Koslow; John M Davis; Martin M Katz; J Mendels; E Robins; P E Stokes; Charles L Bowden
Biological component of the NIMH clinical research branch collaborative program on the psychobiology of depression: I. Background and theoretical considerations.
Psychological medicine 1980;10(4):759-76.
1980: Charles L Bowden; F J Humphrey; M G Thompson
Priorities in psychiatric residency training.
The American journal of psychiatry 1980;137(10):1243-6.
1980: Charles L Bowden; L S Schoenfeld; R L Adams
Mental health attitudes and treatment expectations as treatment variables.
Journal of clinical psychology 1980;36(3):653-7.
1980: Charles L Bowden; F Sarabia
Diagnosing manic-depressive illness in adolescents.
Comprehensive psychiatry 1980;21(4):263-9.
1980: F Sarabia; Charles L Bowden
Computerized tomographic evidence of cerebral atrophy in heavy drinkers.
Southern medical journal 1980;73(6):716-8.
1980: Charles L Bowden; L S Schoenfeld; R L Adams
A correlation between dropout status and improvement in a psychiatric clinic.
Hospital & community psychiatry 1980;31(3):192-5.
1979: C C Barnhart; Charles L Bowden
Toxic psychosis with cimetidine.
The American journal of psychiatry 1979;136(5):725-6.
1979: Charles L Bowden
Recent advances in the benzodiazepines.
Texas medicine 1979;75(1):51-4.
1978: Charles L Bowden; J F Maddux; M Esquivel
Arrests before and during methadone maintenance.
The International journal of the addictions 1978;13(6):921-31.
1978: Charles L Bowden
Lithium-responsive depression.
Comprehensive psychiatry 1978;19(3):227-31.
1977: Charles L Bowden; M B Giffen
Psychotropics and glaucoma.
The American journal of psychiatry 1977;134(11):1314.
1977: Charles L Bowden
The function and organization of NIMH.
The American journal of psychiatry 1977;134(8):939-40.
1976: Charles L Bowden; J F Maddux; M Esquivel
Methadone dispensing by community pharmacies.
The American journal of drug and alcohol abuse 1976;3(2):243-54.
1975: Charles L Bowden; H W Martin
A course on behavioral skills and the psychological aspects of dentistry.
Journal of dental education 1975;39(9):617-21.
1975: Charles L Bowden; D Barton
Goals of medical student psychiatric education.
Journal of medical education 1975;50(3):257-63.
1975: Charles L Bowden
Managing depression in the '70s.
Southern medical journal 1975;68(2):177-83.
1973: Charles L Bowden; T L Vordenbaumen; M Rubin
Methadone maintenance in community pharmacies.
Journal of the American Pharmaceutical Association 1973;13(12):684-6 passim.
1973: S H Rosenthal; Charles L Bowden
A double-blind comparison of thioridazine (Mellaril) versus diazepam (valium) in patients with chronic mixed anxiety and depressive symptoms.
Current therapeutic research, clinical and experimental 1973;15(5):261-7.
1972: J F Maddux; Charles L Bowden
Critique of success with methadone maintenance.
The American journal of psychiatry 1972;129(4):440-6.
1972: Charles L Bowden; J F Maddux
Methadone maintenance: myth and reality.
The American journal of psychiatry 1972;129(4):435-40.
1972: Charles L Bowden; J Endicott; R L Spitzer
A-B therapist variable and psychotherapeutic outcome.
The Journal of nervous and mental disease 1972;154(4):276-90.
1972: Charles L Bowden; A E Reeb
Community psychiatry: Scott County evaluation.
The Journal of the Kentucky Medical Association 1972;70(2):106-8.
1972: Charles L Bowden; B J Langenauer
Success and failure in the NARA addiction program.
The American journal of psychiatry 1972;128(7):853-6.
1971: Charles L Bowden; V M Bowden
A survey of information sources used by psychiatrists.
Bulletin of the Medical Library Association 1971;59(4):603-8.
1971: B J Langenauer; Charles L Bowden
A follow-up study of narcotic addicts in the NARA program.
The American journal of psychiatry 1971;128(1):41-6.
1971: Charles L Bowden
Determinants of initial use of opioids.
Comprehensive psychiatry 1971;12(2):136-40.